Dr. Reddy’s Labs is relaunching its over-the-counter naproxen sodium tablets, a store-brand equivalent of Aleve. The product is available in 220-mg dosage strength.
“The re-launch of Dr. Reddy’s Naproxen Sodium Tablets, 220 mg (OTC), is an important addi-tion to our Pain/Analgesics portfolio of OTC products,” says Marc Kikuchi, CEO of North Ameri-ca generics, at Dr. Reddy’s. “This launch represents our continued endeavor to leverage our strong capabilities and vertically integrated supply chain on key APIs like naproxen to ensure a consistent and reliable supply of finished products for our customers and patients.”
The naproxen sodium tablets are nonsteroidal anti-inflammatory drugs used as a pain reliever and fever reducer. It temporarily relieves minor aches and pains due to arthritis, muscle aches, backache, menstrual cramps, headache, toothache and the common cold.
The product had U.S. sales of roughly $316 million for the year ended July 2021, according to market research firm IRI.
Dr. Reddy’s said it would be offering its product in multiple pack sizes.